Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Mesothelioma
Pemetrexed
Urinary Bladder Neoplasms

Pemetrexed

The field of oncology continually evolves due to ongoing research and advancements in treatment modalities. Pemetrexed is a key chemotherapeutic agent used to treat various cancer types, including non-small cell lung cancer, mesothelioma, bladder cancer, breast cancer, and several other solid tumors. Understanding potential adverse effects, such as hematological toxicities, nephrotoxicity, and hypersensitivity reactions, is crucial for effective patient management and improved quality of life. This clinical activity provides an overview of pemetrexed, including its indications, mechanisms of action, dosing information, infusion protocols, administration methods, and contraindications. Emphasis is placed on patient monitoring and other critical factors during pemetrexed therapy, supported by insights from recent clinical trials and research. The importance of staying informed about new formulations and emerging indications and the need for a patient-centered approach that considers individual patient characteristics, disease stage, and comorbidities are also highlighted.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.